SCHEMBL235599

SCHEMBL235599

C[N+](C)(C)CC[N+](C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
APEX1 P27695 3/20 0.58
ACHE P22303 3/20 0.58
LMNA P02545 3/20 0.58
NFKB1 P19838 2/20 0.58
KDM4E B2RXH2 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
PMP22 Q01453 2/20 0.58
HSD17B10 Q99714 1/20 0.58
HRH3 Q9Y5N1 1/20 0.58
TSHR P16473 1/20 0.58
RAB9A P51151 1/20 0.58
NPSR1 Q6W5P4 1/20 0.54
CYP3A4 P08684 1/20 0.50
SLC5A7 Q9GZV3 1/20 0.50
DNM1 Q05193 6/20 0.44
BBOX1 O75936 1/20 0.39
APAF1 O14727 1/20 0.39
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride Ion SCHEMBL1444803 0.94 MEN1 (0.54) MEN1KMT2AAPEX1ACHELMNA
Water SCHEMBL4489648 0.94 MEN1 (0.54) MEN1KMT2AAPEX1ACHELMNA
Bromide SCHEMBL11130043 0.94 MEN1 (0.61) MEN1KMT2AAPEX1ACHELMNA
Iodide SCHEMBL1982646 0.94 MEN1 (0.54) MEN1KMT2AAPEX1ACHELMNA
Hydrochloric Acid SCHEMBL8339730 0.94 APEX1 (0.61) MEN1KMT2AAPEX1ACHELMNA
SCHEMBL14754176 0.85 MEN1 (0.47) MEN1KMT2AAPEX1ACHELMNA
SCHEMBL10569815 0.82 MEN1 (0.44) MEN1KMT2AAPEX1ACHELMNA
Bicarbonate SCHEMBL6366867 0.78 TSHR (0.50) MEN1KMT2AAPEX1ACHELMNA
SCHEMBL236981 0.78 MEN1 (0.91) MEN1KMT2AAPEX1ACHELMNA
SCHEMBL237389 0.78 MEN1 (0.75) MEN1KMT2AAPEX1ACHELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7578993-B2 Producing novel zeolitic materials using newly designed organoammonium templates UOP LLC (US) 2009-08-25 US claimed
US-20050095195-A1 Process for preparing crystalline aluminosilicate compositions using charge density matching UOP LLC 2005-05-05 US claimed
EP-0839816-B1 The preparation of sulfur-containing organosilicon compounds GOODYEAR TIRE & RUBBER (US) 2004-04-28 EP claimed
EP-0794186-B1 The preparation of sulfur-containing organosilicon compounds GOODYEAR TIRE & RUBBER (US) 2003-05-28 EP claimed
US-6465670-B2 SURFACE TREATMENT USING ORGANOSILICON COMPOUND, SOLVENT AND PHASE TRANSFER CATALYST THE GOODYEAR TIRE & RUBBER COMPANY 2002-10-15 US claimed
US-20020022085-A1 Preparation of surface modified silica GOODYEAR TIRE & RUBBER COMPANY, THE 2002-02-21 US claimed
US-6172251-B1 USING ORGANOSILICON COMPOUNDS THE GOODYEAR TIRE & RUBBER COMPANY 2001-01-09 US claimed
US-6060260-A MIXING POSITIVELY CHARGED MOLECULE WITH A QUATERNARY AMMONIUM BLOCKING AGENT TO PREVENT MOLECULE FROM STICKING TO NEGATIVELY CHARGED SURFACE OF ANALYZERS DADE BEHRING INC. (US) 2000-05-09 US claimed
EP-0839816-A1 The preparation of sulfur-containing organosilicon compounds THE GOODYEAR TIRE & RUBBER COMPANY (US) 1998-05-06 EP claimed
EP-0794186-A1 The preparation of sulfur-containing organosilicon compounds THE GOODYEAR TIRE & RUBBER COMPANY (US) 1997-09-10 EP claimed
US-5663396-A Preparation of sulfur-containing organosilicon compounds THE GOODYEAR TIRE & RUBBER COMPANY (US) 1997-09-02 US claimed
US-5583245-A Preparation of sulfur-containing organosilicon compounds THE GOODYEAR TIRE & RUBBER COMPANY (US) 1996-12-10 US claimed
US-5468893-A Preparation of sulfur-containing organosilicon compounds THE GOODYEAR TIRE & RUBBER COMPANY (US) 1995-11-21 US claimed
US-5405985-A Preparation of sulfur-containing organosilicon compounds THE GOODYEAR TIRE & RUBBER COMPANY (US) 1995-04-11 US claimed
US-4433164-A HYDROHALIDE; PALLADIUM CATALYST; AMMONIUM, PHOSPHONIUM OR ARSONIUM COMPOUND RHONE-POULENC INDUSTRIES (FR) 1984-02-21 US claimed
EP-4658260-A1 TETRATHIOMOLYBDIC ACID FOR USE IN TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS (WILSON DISEASE) Alexion Pharmaceuticals, Inc. (US) 2025-12-10 EP disclosed
US-12252632-B2 Chemical-mechanical polishing composition, rinse composition, chemical- mechanical polishing method, and rinsing method ENTEGRIS, INC. (US) 2025-03-18 US disclosed
US-4522760-A SEPARATION USING NITROGEN, PHOSPHORUS, OR ARSENIC QUATERNARY ONIUMSALT, ALCOHOL, AND HYDROCARBON SOLVENT RHONE-POULENC CHIMIE DE BASE (FR) 1985-06-11 US disclosed
US-4433164-A HYDROHALIDE; PALLADIUM CATALYST; AMMONIUM, PHOSPHONIUM OR ARSONIUM COMPOUND RHONE-POULENC INDUSTRIES (FR) 1984-02-21 US disclosed
US-4267242-A CATHODE COMPRISING A HALOGEN-, CHALCOGENIDE-OR PHOSPHORUS-ABSORBED MOLECULAR SIEVE CARRIERS; BATTERIES SOUTH AFRICAN INVENTIONS DEVELOPMENT CORP. (ZA) 1981-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020022085-A1 Preparation of surface modified silica OSTC, SAMM50, SSRP1 MEN1 2656/4885KMT2A 1421/4885APEX1 2500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.